The Impact of Dietary Changes and Dietary Supplements on Lipid Profile

Canadian Journal of Cardiology

Volumn 27, Issue 4, 2011, Pages 488-505

  Huang, Jingbo ^a   Frohlich, Jiri ^a   Ignaszewski, Andrew P ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOTRIENOL; ASCORBIC ACID; CARBOHYDRATE; CHROMIUM; GLUTAMIC ACID DERIVATIVE; GUGGULSTERONE; ISOFLAVONE; LIPID; OMEGA 3 FATTY ACID; PHYTOSTEROL; POLICOSANOL; PROTEIN; PYRIDOXAL PHOSPHATE GLUTAMATE MAGNESIUM; SOYBEAN PROTEIN; UNCLASSIFIED DRUG; XUEZHIKANG;

CARBOHYDRATE DIET; COCHRANE LIBRARY; DIET; DIET SUPPLEMENTATION; DIET THERAPY; FIBER; GARLIC; GRAIN; HIGH FIBER DIET; HUMAN; LIPID BLOOD LEVEL; LOW FAT DIET; MEDITERRANEAN DIET; MEDLINE; META ANALYSIS; NUT; NUTRITION; OAT; PORTFOLIO DIET; PROTEIN DIET; RANDOMIZED CONTROLLED TRIAL (TOPIC); RED WINE; REVIEW; SYSTEMATIC REVIEW; TEA;

DIET; DIETARY SUPPLEMENTS; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPIDS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 80052183845     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2010.12.077     Document Type: Review

References (154)

1. Petrella R.J., Merikle E. A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in Southwestern Ontario, Canada. Clin Ther 2008, 30:1145-1154.
2. Raine K.D. Addressing poor nutrition to promote heart health: moving upstream. Can J Cardiol 2010, 26(suppl C):21C-24C.
3. Goff D.C., Bertoni A.G., Kramer H., et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 2006, 113:647-656.
4. Thompson P.D., Clarkson P., Karas R.H. Statin-associated myopathy. JAMA 2003, 289:1681-1690.
5. Becker D.J., Gordon R.Y., Morris P.B., et al. Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial. Mayo Clin Proc 2008, 83:758-764.
6. Leopoldo A.S., Sugizaki M.M., Lima-Leopoldo A.P., et al. Cardiac remodeling in a rat model of diet-induced obesity. Can J Cardiol 2010, 26:423-429.
7. Spence J.D., Jenkins D.J., Davignon J. Dietary cholesterol and egg yolks: not for patients at risk of vascular disease. Can J Cardiol 2010, 26:e336-e339.
8. Squadrito F., Altavilla D., Morabito N., et al. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis 2002, 163:339-347.
9. Hale G., Paul-Labrador M., Dwyer J.H., Merz C.N. Isoflavone supplementation and endothelial function in menopausal women. Clin Endocrinol (Oxf) 2002, 56:693-701.
10. Li S.H., Liu X.X., Bai Y.Y., et al. Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am J Clin Nutr 2010, 91:480-486.
11. Baum J.A., Teng H., Erdman J.W., et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 1998, 68:545-551.
12. Crouse J.R., Morgan T., Terry J.G., Ellis J., Vitolins M., Burke G.L. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 1999, 159:2070-2076.
13. Dalais F.S., Ebeling P.R., Kotsopoulos D., McGrath B.P., Teede H.J. The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol (Oxf) 2003, 58:704-709.
14. Gardner C.D., Newell K.A., Cherin R., Haskell W.L. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr 2001, 73:728-735.
15. Hoie L.H., Morgenstern E.C., Gruenwald J., et al. A double-blind placebo-controlled clinical trial compares the cholesterol-lowering effects of two different soy protein preparations in hypercholesterolemic subjects. Eur J Nutr 2005, 44:65-71.
16. Nestel P., Cehun M., Chronopoulos A., DaSilva L., Teede H., McGrath B. A biochanin-enriched isoflavone from red clover lowers LDL cholesterol in men. Eur J Clin Nutr 2004, 58:403-408.
17. Puska P., Korpelainen V., Hoie L.H., Skovlund E., Smerud K.T. Isolated soya protein with standardised levels of isoflavones, cotyledon soya fibres and soya phospholipids improves plasma lipids in hypercholesterolaemia: a double-blind, placebo-controlled trial of a yoghurt formulation. Br J Nutr 2004, 91:393-401.
18. Teede H.J., Dalais F.S., Kotsopoulos D., Liang Y.L., Davis S., McGrath B.P. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 2001, 86:3053-3060.
19. Washburn S., Burke G.L., Morgan T., Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999, 6:7-13.
20. Welty F.K., Lee K.S., Lew N.S., Zhou J.R. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med 2007, 167:1060-1067.
21. Anderson J.W., Johnstone B.M., Cook-Newell M.E. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995, 333:276-282.
22. Reynolds K., Chin A., Lees K.A., Nguyen A., Bujnowski D., He J. A meta-analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol 2006, 98:633-640.
23. Taku K., Umegaki K., Sato Y., Taki Y., Endoh K., Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 2007, 85:1148-1156.
24. Coronary heart disease in seven countries. summary. Circulation 1970, 41(suppl):186-195.
25. Hall W.L., Vafeiadou K., Hallund J., et al. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 2006, 83:592-600.
26. Hermansen K., Hansen B., Jacobsen R., et al. Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects. Eur J Clin Nutr 2005, 59:843-850.
27. Hodgson J.M., Puddey I.B., Beilin L.J., Mori T.A., Croft K.D. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr 1998, 128:728-732.
28. Hoie L.H., Graubaum H.J., Harde A., Gruenwald J., Wernecke K.D. Lipid-lowering effect of 2 dosages of a soy protein supplement in hypercholesterolemia. Adv Ther 2005, 22:175-186.
29. Kreijkamp-Kaspers S., Kok L., Grobbee D.E., et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 2004, 292:65-74.
30. Ma Y., Chiriboga D., Olendzki B.C., Nicolosi R., Merriam P.A., Ockene I.S. Effect of soy protein containing isoflavones on blood lipids in moderately hypercholesterolemic adults: a randomized controlled trial. J Am Coll Nutr 2005, 24:275-285.
31. Anderson J.W., Allgood L.D., Lawrence A., et al. Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr 2000, 71:472-479.
32. Brown L., Rosner B., Willett W.W., Sacks F.M. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999, 69:30-42.
33. Olson B.H., Anderson S.M., Becker M.P., et al. Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta-analysis. J Nutr 1997, 127:1973-1980.
34. Estruch R., Martinez-Gonzalez M.A., Corella D., et al. Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk. J Epidemiol Community Health 2009, 63:582-588.
35. Davidson M.H., Maki K.C., Kong J.C., et al. Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia. Am J Clin Nutr 1998, 67:367-376.
36. Haskell W.L., Spiller G.A., Jensen C.D., Ellis B.K., Gates J.E. Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects. Am J Cardiol 1992, 69:433-439.
37. Jenkins D.J., Kendall C.W., Vuksan V., et al. Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr 2002, 75:834-839.
38. Jensen C.D., Haskell W., Whittam J.H. Long-term effects of water-soluble dietary fiber in the management of hypercholesterolemia in healthy men and women. Am J Cardiol 1997, 79:34-37.
39. MacMahon M., Carless J. Ispaghula husk in the treatment of hypercholesterolaemia: a double-blind controlled study. J Cardiovasc Risk 1998, 5:167-172.
40. Rodriguez-Moran M., Guerrero-Romero F., Lazcano-Burciaga G. Lipid- and glucose-lowering efficacy of Plantago Psyllium in type II diabetes. J Diabetes Complications 1998, 12:273-278.
41. Salas-Salvado J., Farres X., Luque X., et al. Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial. Br J Nutr 2008, 99:1380-1387.
42. Sprecher D.L., Harris B.V., Goldberg A.C., et al. Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- or low-fat diets. Ann Intern Med 1993, 119:545-554.
43. Tai E.S., Fok A.C., Chu R., Tan C.E. A study to assess the effect of dietary supplementation with soluble fibre (Minolest) on lipid levels in normal subjects with hypercholesterolaemia. Ann Acad Med Singapore 1999, 28:209-213.
44. Zunft H.J., Luder W., Harde A., et al. Carob pulp preparation rich in insoluble fibre lowers total and LDL cholesterol in hypercholesterolemic patients. Eur J Nutr 2003, 42:235-242.
45. Christiansen L.I., Lahteenmaki P.L., Mannelin M.R., Seppanen-Laakso T.E., Hiltunen R.V., Yliruusi J.K. Cholesterol-lowering effect of spreads enriched with microcrystalline plant sterols in hypercholesterolemic subjects. Eur J Nutr 2001, 40:66-73.
46. Earnest C.P., Mikus C.R., Lemieux I., Arsenault B.J., Church T.S. Examination of encapsulated phytosterol ester supplementation on lipid indices associated with cardiovascular disease. Nutrition 2007, 23:625-633.
47. Korpela R., Tuomilehto J., Hogstrom P., et al. Safety aspects and cholesterol-lowering efficacy of low fat dairy products containing plant sterols. Eur J Clin Nutr 2006, 60:633-642.
48. Maki K.C., Davidson M.H., Umporowicz D.M., et al. Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am J Clin Nutr 2001, 74:33-43.
49. Maki K.C., Shinnick F., Seeley M.A., et al. Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults. J Nutr 2003, 133:808-813.
50. Tikkanen M.J., Hogstrom P., Tuomilehto J., Keinanen-Kiukaanniemi S., Sundvall J., Karppanen H. Effect of a diet based on low-fat foods enriched with nonesterified plant sterols and mineral nutrients on serum cholesterol. Am J Cardiol 2001, 88:1157-1162.
51. Weststrate J.A., Meijer G.W. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1998, 52:334-343.
52. Demonty I., Ras R.T., van der Knaap H.C., et al. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J Nutr 2009, 139:271-284.
53. Chen J.T., Wesley R., Shamburek R.D., Pucino F., Csako G. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy 2005, 25:171-183.
54. Kelly S.A., Summerbell C.D., Brynes A., Whittaker V., Frost G. Wholegrain cereals for coronary heart disease. Cochrane Database Syst Rev 2007, 2. CD005051.
55. Keenan J.M., Wenz J.B., Myers S., Ripsin C., Huang Z.Q. Randomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects. J Fam Pract 1991, 33:600-608.
56. Onning G., Wallmark A., Persson M., Akesson B., Elmstahl S., Oste R. Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia. Ann Nutr Metab 1999, 43:301-309.
57. Wien M.A., Sabate J.M., Ikle D.N., Cole S.E., Kandeel F.R. Almonds vs complex carbohydrates in a weight reduction program. Int J Obes Relat Metab Disord 2003, 27:1365-1372.
58. Zambon D., Sabate J., Munoz S., et al. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women: a randomized crossover trial. Ann Intern Med 2000, 132:538-546.
59. Hsu C.H., Tsai T.H., Kao Y.H., Hwang K.C., Tseng T.Y., Chou P. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 2008, 27:363-370.
60. Hansen A.S., Marckmann P., Dragsted L.O., Finne Nielsen I.L., Nielsen S.E., Gronbaek M. Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease. Eur J Clin Nutr 2005, 59:449-455.
61. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
62. Howell W.H., McNamara D.J., Tosca M.A., Smith B.T., Gaines J.A. Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis. Am J Clin Nutr 1997, 65:1747-1764.
63. Tang J.L., Armitage J.M., Lancaster T., Silagy C.A., Fowler G.H., Neil H.A. Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. BMJ 1998, 316:1213-1220.
64. Yu-Poth S., Zhao G., Etherton T., Naglak M., Jonnalagadda S., Kris-Etherton P.M. Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999, 69:632-646.
65. Anderson J.W. Diet, lipids and cardiovascular disease in women. J Am Coll Nutr 1993, 12:433-437.
66. Aquilani R., Tramarin R., Pedretti R.F., et al. Despite good compliance, very low fat diet alone does not achieve recommended cholesterol goals in outpatients with coronary heart disease. Eur Heart J 1999, 20:1020-1029.
67. Davidson M.H., Kong J.C., Drennan K.B., Story K., Anderson G.H. Efficacy of the National Cholesterol Education Program Step I diet: a randomized trial incorporating quick-service foods. Arch Intern Med 1996, 156:305-312.
68. Gardner C.D., Coulston A., Chatterjee L., Rigby A., Spiller G., Farquhar J.W. The effect of a plant-based diet on plasma lipids in hypercholesterolemic adults: a randomized trial. Ann Intern Med 2005, 142:725-733.
69. Ginsberg H.N., Kris-Etherton P., Dennis B., et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol 1998, 18:441-449.
70. Hellenius M.L., de Faire U., Berglund B., Hamsten A., Krakau I. Diet and exercise are equally effective in reducing risk for cardiovascular disease: results of a randomized controlled study in men with slightly to moderately raised cardiovascular risk factors. Atherosclerosis 1993, 103:81-91.
71. Hunninghake D.B., Stein E.A., Dujovne C.A., et al. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med 1993, 328:1213-1219.
72. Insull W., Silvers A., Hicks L., Probstfield J.L. Plasma lipid effects of three common vegetable oils in reduced-fat diets of free-living adults. Am J Clin Nutr 1994, 60:195-202.
73. Knopp R.H., Walden C.E., Retzlaff B.M., et al. Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men: the Dietary Alternatives Study. JAMA 1997, 278:1509-1515.
74. McCarron D.A., Oparil S., Chait A., et al. Nutritional management of cardiovascular risk factors. A randomized clinical trial. Arch Intern Med 1997, 157:169-177.
75. Retzlaff B.M., Walden C.E., Dowdy A.A., McCann B.S., Anderson K.V., Knopp R.H. Changes in plasma triacylglycerol concentrations among free-living hyperlipidemic men adopting different carbohydrate intakes over 2 y: the Dietary Alternatives Study. Am J Clin Nutr 1995, 62:988-995.
76. Sarkkinen E.S., Uusitupa M.I., Pietinen P., et al. Long-term effects of three fat-modified diets in hypercholesterolemic subjects. Atherosclerosis 1994, 105:9-23.
77. Walden C.E., Retzlaff B.M., Buck B.L., McCann B.S., Knopp R.H. Lipoprotein lipid response to the National Cholesterol Education Program step II diet by hypercholesterolemic and combined hyperlipidemic women and men. Arterioscler Thromb Vasc Biol 1997, 17:375-382.
78. Farnsworth E., Luscombe N.D., Noakes M., Wittert G., Argyiou E., Clifton P.M. Effect of a high-protein, energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and obese hyperinsulinemic men and women. Am J Clin Nutr 2003, 78:31-39.
79. Swain J.F., McCarron P.B., Hamilton E.F., Sacks F.M., Appel L.J. Characteristics of the diet patterns tested in the optimal macronutrient intake trial to prevent heart disease (OmniHeart): options for a heart-healthy diet. J Am Diet Assoc 2008, 108:257-265.
80. Estruch R., Martinez-Gonzalez M.A., Corella D., et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006, 145:1-11.
81. Esposito K., Marfella R., Ciotola M., et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292:1440-1446.
82. Jula A., Marniemi J., Huupponen R., Virtanen A., Rastas M., Ronnemaa T. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. JAMA 2002, 287:598-605.
83. Perez-Jimenez F., Lopez-Miranda J., Pinillos M.D., et al. A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons. Diabetologia 2001, 44:2038-2043.
84. Vincent-Baudry S., Defoort C., Gerber M., et al. The Medi-RIVAGE study: reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet. Am J Clin Nutr 2005, 82:964-971.
85. Papadaki A., Scott J.A. Follow-up of a web-based tailored intervention promoting the Mediterranean diet in Scotland. Patient Educ Couns 2008, 73:256-263.
86. Sofi F., Abbate R., Gensini G.F., Casini A. [Evidences on the relationship between Mediterranean diet and health status]. Recenti Prog Med 2009, 100:127-131.
87. de Lorgeril M., Salen P., Martin J.L., Monjaud I., Delaye J., Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999, 99:779-785.
88. Jenkins D.J., Kendall C.W., Faulkner D.A., et al. Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am J Clin Nutr 2006, 83:582-591.
89. Lukaczer D., Liska D.J., Lerman R.H., et al. Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women. Nutrition 2006, 22:104-113.
90. Bucher H.C., Hengstler P., Schindler C., Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002, 112:298-304.
91. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447-455. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
92. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
93. Davidson M.H., Stein E.A., Bays H.E., et al. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther 2007, 29:1354-1367.
94. Larkin T.A., Astheimer L.B., Price W.E. Dietary combination of soy with a probiotic or prebiotic food significantly reduces total and LDL cholesterol in mildly hypercholesterolaemic subjects. Eur J Clin Nutr 2009, 63:238-245.
95. Lovegrove J.A., Lovegrove S.S., Lesauvage S.V., et al. Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians. Am J Clin Nutr 2004, 79:974-982.
96. Noone E.J., Roche H.M., Nugent A.P., Gibney M.J. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 2002, 88:243-251.
97. Saito Y., Yokoyama M., Origasa H., et al. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 2008, 200:135-140.
98. Singh R.B., Niaz M.A., Sharma J.P., Kumar R., Rastogi V., Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--4. Cardiovasc Drugs Ther 1997, 11:485-491.
99. Svensson M., Schmidt E.B., Jorgensen K.A., Christensen J.H. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Nephrol Dial Transplant 2008, 23:2918-2924.
100. Toft I., Bonaa K.H., Ingebretsen O.C., Nordoy A., Jenssen T. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension: a randomized, controlled trial. Ann Intern Med 1995, 123:911-918.
101. Woodman R.J., Mori T.A., Burke V., Puddey I.B., Watts G.F., Beilin L.J. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002, 76:1007-1015.
102. Bemelmans W.J., Broer J., Feskens E.J., et al. Effect of an increased intake of alpha-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) study. Am J Clin Nutr 2002, 75:221-227.
103. Harper C.R., Edwards M.C., Jacobson T.A. Flaxseed oil supplementation does not affect plasma lipoprotein concentration or particle size in human subjects. J Nutr 2006, 136:2844-2848.
104. Kaul N., Kreml R., Austria J.A., et al. A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. J Am Coll Nutr 2008, 27:51-58.
105. von Schacky C., Angerer P., Kothny W., Theisen K., Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999, 130:554-562.
106. Leaf A., Jorgensen M.B., Jacobs A.K., et al. Do fish oils prevent restenosis after coronary angioplasty?. Circulation 1994, 90:2248-2257.
107. Wang C., Harris W.S., Chung M., et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006, 84:5-17.
108. Liu J., Zhang J., Shi Y., Grimsgaard S., Alraek T., Fonnebo V. Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials. Chin Med 2006, 1:4.
109. Heber D., Yip I., Ashley J.M., Elashoff D.A., Elashoff R.M., Go V.L. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr 1999, 69:231-236.
110. Lin C.C., Li T.C., Lai M.M. Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia. Eur J Endocrinol 2005, 153:679-686.
111. Lu Z., Kou W., Du B., et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am J Cardiol 2008, 101:1689-1693.
112. Canetti M., Moreira M., Mas R., et al. A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia. Int J Clin Pharmacol Res 1995, 15:159-165.
113. Castano G., Mas R., Fernandez J.C., Fernandez L., Illnait J., Lopez E. Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia. Drugs R D 2002, 3:159-172.
114. Castano G., Mas R., Fernandez L., et al. Effects of policosanol on postmenopausal women with type II hypercholesterolemia. Gynecol Endocrinol 2000, 14:187-195.
115. Castano G., Mas R., Fernandez L., Illnait J., Gamez R., Alvarez E. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study. Int J Clin Pharmacol Res 2001, 21:43-57.
116. Crespo N., Illnait J., Mas R., Fernandez L., Fernandez J., Castano G. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus. Int J Clin Pharmacol Res 1999, 19:117-127.
117. Mas R., Castano G., Illnait J., et al. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clin Pharmacol Ther 1999, 65:439-447.
118. Mirkin A., Mas R., Martinto M., et al. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women. Int J Clin Pharmacol Res 2001, 21:31-41.
119. Fernandez L., Illnait J., Fernandez J. Policosanol: Results of a postmarketing surveillance control on 27,879 patients. Curr Ther Res Clin Exp 1998, 59:717-722.
120. Singh R.B., Niaz M.A., Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther 1994, 8:659-664.
121. Szapary P.O., Wolfe M.L., Bloedon L.T., et al. Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA 2003, 290:765-772.
122. Gardner C.D., Chatterjee L.M., Carlson J.J. The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults. Atherosclerosis 2001, 154:213-220.
123. Isaacsohn J.L., Moser M., Stein E.A., et al. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med 1998, 158:1189-1194.
124. Neil H.A., Silagy C.A., Lancaster T., et al. Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis. J R Coll Physicians Lond 1996, 30:329-334.
125. Satitvipawee P., Rawdaree P., Indrabhakti S., Ratanasuwan T., Getn-gern P., Viwatwongkasem C. No effect of garlic extract supplement on serum lipid levels in hypercholesterolemic subjects. J Med Assoc Thai 2003, 86:750-757.
126. Superko H.R., Krauss R.M. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a). J Am Coll Cardiol 2000, 35:321-326.
127. Tanamai J., Veeramanomai S., Indrakosas N. The efficacy of cholesterol-lowering action and side effects of garlic enteric coated tablets in man. J Med Assoc Thai 2004, 87:1156-1161.
128. Zhang L., Gail M.H., Wang Y.Q., et al. A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins. Am J Clin Nutr 2006, 84:912-919.
129. Reinhart K.M., Talati R., White C.M., Coleman C.I. The impact of garlic on lipid parameters: a systematic review and meta-analysis. Nutr Res Rev 2009, 22:39-48.
130. Silagy C., Neil A. Garlic as a lipid lowering agent: a meta-analysis. J R Coll Physicians Lond 1994, 28:39-45.
131. Stevinson C., Pittler M.H., Ernst E. Garlic for treating hypercholesterolemia: a meta-analysis of randomized clinical trials. Ann Intern Med 2000, 133:420-429.
132. Warshafsky S., Kamer R.S., Sivak S.L. Effect of garlic on total serum cholesterol: a meta-analysis. Ann Intern Med 1993, 119:599-605.
133. Roeback J.R., Hla K.M., Chambless L.E., Fletcher R.H. Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers: a randomized, controlled trial. Ann Intern Med 1991, 115:917-924.
134. Hajjar I.M., George V., Sasse E.A., Kochar M.S. A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am J Ther 2002, 9:289-293.
135. Kim M.K., Sasaki S., Sasazuki S., Okubo S., Hayashi M., Tsugane S. Long-term vitamin C supplementation has no markedly favourable effect on serum lipids in middle-aged Japanese subjects. Br J Nutr 2004, 91:81-90.
136. Englisch W., Beckers C., Unkauf M., Ruepp M., Zinserling V. Efficacy of artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschung 2000, 50:260-265.
137. Schuitemaker G.E., van der Pol G.A., Aretz C.P., Dinant G.J. A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical-chemical risk factors of cardiovascular disease in a primary care setting. Eur J Clin Pharmacol 2001, 56:857-863.
138. Mustad V.A., Smith C.A., Ruey P.P., Edens N.K., DeMichele S.J. Supplementation with 3 compositionally different tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemia. Am J Clin Nutr 2002, 76:1237-1243.
139. Ho S.C., Tai E.S., Eng P.H., Tan C.E., Fok A.C. In the absence of dietary surveillance, chitosan does not reduce plasma lipids or obesity in hypercholesterolaemic obese Asian subjects. Singapore Med J 2001, 42:6-10.
140. Tricoci P., Allen J.M., Kramer J.M., Califf R.M., Smith S.C. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009, 301:831-841.
141. Kris-Etherton P., Eckel R.H., Howard B.V., St Jeor S., Bazzarre T.L. AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I dietary pattern on cardiovascular disease. Circulation 2001, 103:1823-1825.
142. Jenkins D.J., Kendall C.W., Axelsen M., Augustin L.S., Vuksan V. Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease. Curr Opin Lipidol 2000, 11:49-56.
143. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998, 67:577S-582S.
144. Michalsen A., Lehmann N., Pithan C., et al. Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease. Eur J Clin Nutr 2006, 60:478-485.
145. Bowden R.G., Jitomir J., Wilson R.L., Gentile M. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients. J Ren Nutr 2009, 19:259-266.
146. Maki K.C., Van Elswyk M.E., McCarthy D., et al. Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol. J Am Coll Nutr 2005, 24:189-199.
147. Dodin S., Lemay A., Jacques H., Legare F., Forest J.C., Masse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 2005, 90:1390-1397.
148. Riserus U., Arner P., Brismar K., Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002, 25:1516-1521.
149. Johansen O., Brekke M., Seljeflot I., Abdelnoor M., Arnesen H. N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol 1999, 33:1619-1626.
150. Bairati I., Roy L., Meyer F. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 1992, 85:950-956.
151. Becker D.J., Gordon R.Y., Halbert S.C., French B., Morris P.B., Rader D.J. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med 2009, 150:830-839. W147-9.
152. Berthold H.K., Unverdorben S., Degenhardt R., Bulitta M., Gouni-Berthold I. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA 2006, 295:2262-2269.
153. Lin Y., Rudrum M., van der Wielen R.P., et al. Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations. Metabolism 2004, 53:1309-1314.
154. Mader F.H. Treatment of hyperlipidaemia with garlic-powder tablets: Evidence from the German Association of General Practitioners' multicentric placebo-controlled double-blind study. Arzneimittelforschung 1990, 40:1111-1116.